BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 21094191)

  • 21. Liposomal and nonliposomal drug pharmacokinetics after administration of liposome-encapsulated vincristine and their contribution to drug tissue distribution properties.
    Krishna R; Webb MS; St Onge G; Mayer LD
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1206-12. PubMed ID: 11504822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of smart solid lipid nanoparticles to enhance the efficacy of 5-fluorouracil in the treatment of colorectal cancer.
    Smith T; Affram K; Nottingham EL; Han B; Amissah F; Krishnan S; Trevino J; Agyare E
    Sci Rep; 2020 Oct; 10(1):16989. PubMed ID: 33046724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. L-Cysteine conjugated poly L-lactide nanoparticles containing 5-fluorouracil: formulation, characterization, release and uptake by tissues in vivo.
    Mishra BJ; Kaul A; Trivedi P
    Drug Deliv; 2015 Feb; 22(2):214-22. PubMed ID: 24524408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic efficacy of a lipid-based prodrug of mitomycin C in pegylated liposomes: studies with human gastro-entero-pancreatic ectopic tumor models.
    Gabizon A; Amitay Y; Tzemach D; Gorin J; Shmeeda H; Zalipsky S
    J Control Release; 2012 Jun; 160(2):245-53. PubMed ID: 22134116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formation of transition metal-doxorubicin complexes inside liposomes.
    Abraham SA; Edwards K; Karlsson G; MacIntosh S; Mayer LD; McKenzie C; Bally MB
    Biochim Biophys Acta; 2002 Sep; 1565(1):41-54. PubMed ID: 12225851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of a liposomal copper(II)-quercetin formulation suitable for parenteral use.
    Chen KTJ; Anantha M; Leung AWY; Kulkarni JA; Militao GGC; Wehbe M; Sutherland B; Cullis PR; Bally MB
    Drug Deliv Transl Res; 2020 Feb; 10(1):202-215. PubMed ID: 31482519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrinβ6-targeted immunoliposomes mediate tumor-specific drug delivery and enhance therapeutic efficacy in colon carcinoma.
    Liang B; Shahbaz M; Wang Y; Gao H; Fang R; Niu Z; Liu S; Wang B; Sun Q; Niu W; Liu E; Wang J; Niu J
    Clin Cancer Res; 2015 Mar; 21(5):1183-95. PubMed ID: 25549721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nano-erythrocyte membrane-chaperoned 5-fluorouracil liposomes as biomimetic delivery platforms to target hepatocellular carcinoma cell lines.
    AlQahtani SA; Harisa GI; Badran MM; AlGhamdi KM; Kumar A; Salem-Bekhit MM; Ahmad SF; Alanazi FK
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):989-996. PubMed ID: 30873877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel liposomal irinotecan formulation with significant anti-tumour activity: use of the divalent cation ionophore A23187 and copper-containing liposomes to improve drug retention.
    Ramsay E; Alnajim J; Anantha M; Zastre J; Yan H; Webb M; Waterhouse D; Bally M
    Eur J Pharm Biopharm; 2008 Mar; 68(3):607-17. PubMed ID: 17904831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro cytotoxicity, in vivo biodistribution and antitumor activity of HPMA copolymer-5-fluorouracil conjugates.
    Yuan F; Qin X; Zhou D; Xiang QY; Wang MT; Zhang ZR; Huang Y
    Eur J Pharm Biopharm; 2008 Nov; 70(3):770-6. PubMed ID: 18656539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative study of transfersomes, liposomes, and niosomes for topical delivery of 5-fluorouracil to skin cancer cells: preparation, characterization, in-vitro release, and cytotoxicity analysis.
    Alvi IA; Madan J; Kaushik D; Sardana S; Pandey RS; Ali A
    Anticancer Drugs; 2011 Sep; 22(8):774-82. PubMed ID: 21799471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Simple and Improved Active Loading Method to Efficiently Encapsulate Staurosporine into Lipid-Based Nanoparticles for Enhanced Therapy of Multidrug Resistant Cancer.
    Tang WL; Chen WC; Roy A; Undzys E; Li SD
    Pharm Res; 2016 May; 33(5):1104-14. PubMed ID: 26758590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A targeted liposome delivery system for combretastatin A4: formulation optimization through drug loading and in vitro release studies.
    Nallamothu R; Wood GC; Kiani MF; Moore BM; Horton FP; Thoma LA
    PDA J Pharm Sci Technol; 2006; 60(3):144-55. PubMed ID: 17089683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liposome formulation of a novel hydrophobic aryl-imidazole compound for anti-cancer therapy.
    Liu J; Lee H; Huesca M; Young A; Allen C
    Cancer Chemother Pharmacol; 2006 Sep; 58(3):306-18. PubMed ID: 16333677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimized thermosensitive liposomes for selective doxorubicin delivery: formulation development, quality analysis and bioactivity proof.
    Levacheva I; Samsonova O; Tazina E; Beck-Broichsitter M; Levachev S; Strehlow B; Baryshnikova M; Oborotova N; Baryshnikov A; Bakowsky U
    Colloids Surf B Biointerfaces; 2014 Sep; 121():248-56. PubMed ID: 25001189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel 5-Fluorouracil targeted delivery to colon cancer using folic acid conjugated liposomes.
    Handali S; Moghimipour E; Rezaei M; Ramezani Z; Kouchak M; Amini M; Angali KA; Saremy S; Dorkoosh FA
    Biomed Pharmacother; 2018 Dec; 108():1259-1273. PubMed ID: 30372827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil.
    Yadav AK; Agarwal A; Rai G; Mishra P; Jain S; Mishra AK; Agrawal H; Agrawal GP
    Drug Deliv; 2010 Nov; 17(8):561-72. PubMed ID: 20738221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro and in vivo reversal of resistance to 5-fluorouracil in colorectal cancer cells with a novel stealth double-liposomal formulation.
    Fanciullino R; Giacometti S; Mercier C; Aubert C; Blanquicett C; Piccerelle P; Ciccolini J
    Br J Cancer; 2007 Oct; 97(7):919-26. PubMed ID: 17848948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stealth recombinant human serum albumin nanoparticles conjugating 5-fluorouracil augmented drug delivery and cytotoxicity in human colon cancer, HT-29 cells.
    Sharma A; Kaur A; Jain UK; Chandra R; Madan J
    Colloids Surf B Biointerfaces; 2017 Jul; 155():200-208. PubMed ID: 28431329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coencapsulation of irinotecan and floxuridine into low cholesterol-containing liposomes that coordinate drug release in vivo.
    Tardi PG; Gallagher RC; Johnstone S; Harasym N; Webb M; Bally MB; Mayer LD
    Biochim Biophys Acta; 2007 Mar; 1768(3):678-87. PubMed ID: 17208196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.